Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
2.
Lancet Glob Health ; 11(12): e1978-e1985, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-37973345

RESUMO

UN member states have committed to universal health coverage (UHC) to ensure all individuals and communities receive the health services they need without suffering financial hardship. Although the pursuit of UHC should unify disparate global health challenges, it is too commonly seen as another standalone initiative with a singular focus on the health sector. Despite constituting the cornerstone of the health-related Sustainable Development Goals, UHC-related commitments, actions, and metrics do not engage with the major drivers and determinants of health, such as poverty, gender inequality, discriminatory laws and policies, environment, housing, education, sanitation, and employment. Given that all countries already face multiple competing health priorities, the global UHC agenda should be used to reconcile, rationalise, prioritise, and integrate investments and multisectoral actions that influence health. In this paper, we call for greater coordination and coherence using a UHC+ lens to suggest new approaches to funding that can extend beyond biomedical health services to include the cross-cutting determinants of health. The proposed intersectoral co-financing mechanisms aim to support the advancement of health for all, regardless of countries' income.


Assuntos
Saúde Global , Cobertura Universal do Seguro de Saúde , Humanos , Serviços de Saúde , Pobreza , Governo , Financiamento da Assistência à Saúde
3.
Ann Glob Health ; 89(1): 46, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37425141

RESUMO

Noncommunicable diseases (NCDs) are the leading cause of premature mortality worldwide. Corporate interests are sometimes well-aligned with public health, but profiteering from the consumption of products that are known to be the major contributors to the noncommunicable disease burden undermines public health. This paper describes the key industry actors shaping the NCD landscape; highlights the unhealthy commodities' impact on health and the growing burden of NCDs; and outlines challenges and opportunities to reduce exposure to those risk factors. Corporations deploy a wide array of strategies to maximize profits at the expense of health, including sophisticated marketing techniques, interference in the policy-making process, opposition and distortion of research and evidence, and whitewashing of health-harming activities through corporate social responsibility initiatives. There can be no shared value for industries that sell goods that harm health irrespective of consumption patterns (such as tobacco and likely alcohol), so government actions such as regulation and legislation are the only viable policy instruments. Where shared value is possible (for example, with the food industry), industry engagement can potentially realign corporate interests with the public health interest for mutual benefit. Deliberate, careful, and nuanced approaches to engagement are required.


Assuntos
Doenças não Transmissíveis , Humanos , Doenças não Transmissíveis/prevenção & controle , Setor Privado , Formulação de Políticas , Fatores de Risco , Política de Saúde
5.
Front Public Health ; 11: 1183712, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37483915

RESUMO

Noncommunicable diseases (NCDs) and maternal newborn and child health (MNCH) are two deeply intertwined health areas that have been artificially separated by global health policies, resource allocations and programming. Optimal MNCH care can provide a unique opportunity to screen for, prevent and manage early signs of NCDs developing in both the woman and the neonate. This paper considers how NCDs, NCD modifiable risk factors, and NCD metabolic risk factors impact MNCH. We argue that integrated management is essential, but this faces challenges that manifest across all levels of domestic health systems. Progress toward Sustainable Development targets requires joined-up action.


Assuntos
Doenças não Transmissíveis , Criança , Feminino , Recém-Nascido , Humanos , Doenças não Transmissíveis/prevenção & controle , Desenvolvimento Sustentável , Saúde da Criança , Fatores de Risco , Saúde Global
6.
Ann Glob Health ; 86(1): 133, 2020 10 08.
Artigo em Inglês | MEDLINE | ID: mdl-33102153

RESUMO

The COVID-19 pandemic has highlighted vast differences across countries in their responses to the emergency and their capacities to implement public health measures that could slow the progression of the disease. As public health systems are the first line of defense during pandemics, it has become clear that sustained investment in strengthening public health infrastructure is a major need in all countries, irrespective of income levels. Drawing on the successful experiences of Switzerland, Georgia, and New Zealand in dealing with COVID-19, we suggest prioritizing core public health capacities with links to the International Health Regulations, improving international cooperation, coordination, and multisectoral action, addressing health inequities by targeting vulnerable groups, and enhancing health literacy, including through sophisticated and sustained communication campaigns to build resilience. These measures will ensure that health systems and communities will be better prepared for the disruptions that future disease outbreaks will inevitably bring.


Assuntos
Controle de Doenças Transmissíveis , Infecções por Coronavirus , Atenção à Saúde , Saúde Global/normas , Pandemias/prevenção & controle , Pneumonia Viral , Saúde Pública/métodos , Betacoronavirus , COVID-19 , Defesa Civil , Controle de Doenças Transmissíveis/métodos , Controle de Doenças Transmissíveis/organização & administração , Controle de Doenças Transmissíveis/normas , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/prevenção & controle , Atenção à Saúde/organização & administração , Atenção à Saúde/normas , Humanos , Cooperação Internacional , Colaboração Intersetorial , Pneumonia Viral/epidemiologia , Pneumonia Viral/prevenção & controle , Melhoria de Qualidade , SARS-CoV-2 , Fatores Socioeconômicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA